ARHGDIB and gastric cancer: Recently, we demonstrated that phospholipase C-gamma (PLCγ) is activated in RhoGDI2-overexpressing SNU-484 cells, and that it is required for RhoGDI2-mediated cisplatin resistance and cancer cell invasion in gastric cancer [45].